nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNH1—embryo—muscle cancer	0.0265	0.0279	CbGeAlD
Dalfampridine—KCNV1—renal system—muscle cancer	0.0222	0.0233	CbGeAlD
Dalfampridine—KCNA7—tendon—muscle cancer	0.0217	0.0228	CbGeAlD
Dalfampridine—KCNG2—testis—muscle cancer	0.0201	0.0212	CbGeAlD
Dalfampridine—KCND1—embryo—muscle cancer	0.0197	0.0207	CbGeAlD
Dalfampridine—KCNG4—head—muscle cancer	0.0186	0.0195	CbGeAlD
Dalfampridine—KCNH4—head—muscle cancer	0.0186	0.0195	CbGeAlD
Dalfampridine—KCNB2—head—muscle cancer	0.0186	0.0195	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—muscle cancer	0.018	0.0189	CbGeAlD
Dalfampridine—KCNH5—head—muscle cancer	0.017	0.0179	CbGeAlD
Dalfampridine—KCNS2—head—muscle cancer	0.0158	0.0166	CbGeAlD
Dalfampridine—KCNA6—head—muscle cancer	0.0158	0.0166	CbGeAlD
Dalfampridine—KCNV1—head—muscle cancer	0.0148	0.0156	CbGeAlD
Dalfampridine—KCNV2—head—muscle cancer	0.0141	0.0148	CbGeAlD
Dalfampridine—KCNV2—testis—muscle cancer	0.0136	0.0143	CbGeAlD
Dalfampridine—KCNG3—head—muscle cancer	0.0134	0.0141	CbGeAlD
Dalfampridine—KCNC2—head—muscle cancer	0.0134	0.0141	CbGeAlD
Dalfampridine—KCNH1—head—muscle cancer	0.0134	0.0141	CbGeAlD
Dalfampridine—KCNH1—testis—muscle cancer	0.013	0.0136	CbGeAlD
Dalfampridine—KCNG1—vagina—muscle cancer	0.013	0.0136	CbGeAlD
Dalfampridine—KCNG1—head—muscle cancer	0.012	0.0126	CbGeAlD
Dalfampridine—KCNH3—head—muscle cancer	0.012	0.0126	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—muscle cancer	0.0118	0.0125	CbGeAlD
Dalfampridine—KCNC4—tendon—muscle cancer	0.0116	0.0122	CbGeAlD
Dalfampridine—KCNB1—head—muscle cancer	0.0116	0.0122	CbGeAlD
Dalfampridine—KCNH8—head—muscle cancer	0.0116	0.0122	CbGeAlD
Dalfampridine—KCNG1—testis—muscle cancer	0.0116	0.0122	CbGeAlD
Dalfampridine—KCNH3—testis—muscle cancer	0.0116	0.0122	CbGeAlD
Dalfampridine—KCNA5—renal system—muscle cancer	0.0114	0.012	CbGeAlD
Dalfampridine—KCNS1—vagina—muscle cancer	0.0113	0.0119	CbGeAlD
Dalfampridine—KCNC3—head—muscle cancer	0.0113	0.0118	CbGeAlD
Dalfampridine—KCNH8—testis—muscle cancer	0.0112	0.0118	CbGeAlD
Dalfampridine—KCNS3—renal system—muscle cancer	0.0112	0.0117	CbGeAlD
Dalfampridine—KCNQ4—tendon—muscle cancer	0.0112	0.0117	CbGeAlD
Dalfampridine—KCNA4—head—muscle cancer	0.0109	0.0115	CbGeAlD
Dalfampridine—KCNA3—head—muscle cancer	0.0109	0.0115	CbGeAlD
Dalfampridine—KCNC3—testis—muscle cancer	0.0109	0.0114	CbGeAlD
Dalfampridine—KCNQ5—tendon—muscle cancer	0.0109	0.0114	CbGeAlD
Dalfampridine—KCND1—vagina—muscle cancer	0.0108	0.0113	CbGeAlD
Dalfampridine—KCNA2—head—muscle cancer	0.0104	0.0109	CbGeAlD
Dalfampridine—KCNS1—head—muscle cancer	0.0104	0.0109	CbGeAlD
Dalfampridine—KCNA5—cardiac atrium—muscle cancer	0.0102	0.0107	CbGeAlD
Dalfampridine—KCNH6—renal system—muscle cancer	0.0102	0.0107	CbGeAlD
Dalfampridine—KCNQ5—vagina—muscle cancer	0.0101	0.0106	CbGeAlD
Dalfampridine—KCNA2—testis—muscle cancer	0.0101	0.0106	CbGeAlD
Dalfampridine—KCNS1—testis—muscle cancer	0.0101	0.0106	CbGeAlD
Dalfampridine—KCND1—head—muscle cancer	0.00996	0.0105	CbGeAlD
Dalfampridine—KCNC4—head—muscle cancer	0.00996	0.0105	CbGeAlD
Dalfampridine—KCNF1—tendon—muscle cancer	0.00995	0.0105	CbGeAlD
Dalfampridine—KCNC4—testis—muscle cancer	0.00962	0.0101	CbGeAlD
Dalfampridine—KCND1—testis—muscle cancer	0.00962	0.0101	CbGeAlD
Dalfampridine—KCNH7—head—muscle cancer	0.00957	0.0101	CbGeAlD
Dalfampridine—KCNC1—head—muscle cancer	0.00957	0.0101	CbGeAlD
Dalfampridine—KCNQ4—head—muscle cancer	0.00957	0.0101	CbGeAlD
Dalfampridine—KCNQ5—head—muscle cancer	0.00931	0.00979	CbGeAlD
Dalfampridine—KCNH7—testis—muscle cancer	0.00924	0.00972	CbGeAlD
Dalfampridine—KCNC1—testis—muscle cancer	0.00924	0.00972	CbGeAlD
Dalfampridine—KCNQ4—testis—muscle cancer	0.00924	0.00972	CbGeAlD
Dalfampridine—KCNF1—vagina—muscle cancer	0.00923	0.00971	CbGeAlD
Dalfampridine—KCNA5—tendon—muscle cancer	0.0089	0.00936	CbGeAlD
Dalfampridine—KCNS3—tendon—muscle cancer	0.00871	0.00916	CbGeAlD
Dalfampridine—KCNF1—head—muscle cancer	0.00853	0.00897	CbGeAlD
Dalfampridine—KCNA5—vagina—muscle cancer	0.00826	0.00868	CbGeAlD
Dalfampridine—KCNQ1—renal system—muscle cancer	0.00821	0.00864	CbGeAlD
Dalfampridine—KCNS3—vagina—muscle cancer	0.00808	0.0085	CbGeAlD
Dalfampridine—KCNA5—head—muscle cancer	0.00763	0.00802	CbGeAlD
Dalfampridine—KCND3—cardiac atrium—muscle cancer	0.0076	0.00799	CbGeAlD
Dalfampridine—KCNS3—head—muscle cancer	0.00747	0.00786	CbGeAlD
Dalfampridine—KCNQ3—head—muscle cancer	0.00747	0.00786	CbGeAlD
Dalfampridine—KCNA5—testis—muscle cancer	0.00737	0.00775	CbGeAlD
Dalfampridine—KCNQ1—cardiac atrium—muscle cancer	0.00735	0.00774	CbGeAlD
Dalfampridine—KCNS3—testis—muscle cancer	0.00721	0.00759	CbGeAlD
Dalfampridine—KCNQ2—head—muscle cancer	0.00687	0.00723	CbGeAlD
Dalfampridine—KCNH6—head—muscle cancer	0.00682	0.00717	CbGeAlD
Dalfampridine—KCNA1—tendon—muscle cancer	0.00665	0.007	CbGeAlD
Dalfampridine—KCNQ2—testis—muscle cancer	0.00664	0.00698	CbGeAlD
Dalfampridine—KCND2—head—muscle cancer	0.00651	0.00685	CbGeAlD
Dalfampridine—KCND2—testis—muscle cancer	0.00629	0.00661	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—muscle cancer	0.00621	0.00653	CbGeAlD
Dalfampridine—KCNA1—head—muscle cancer	0.0057	0.006	CbGeAlD
Dalfampridine—KCND3—head—muscle cancer	0.00567	0.00597	CbGeAlD
Dalfampridine—KCNQ1—head—muscle cancer	0.00549	0.00578	CbGeAlD
Dalfampridine—KCND3—testis—muscle cancer	0.00548	0.00577	CbGeAlD
Dalfampridine—KCNQ1—testis—muscle cancer	0.00531	0.00558	CbGeAlD
Dalfampridine—KCNH2—renal system—muscle cancer	0.00313	0.00329	CbGeAlD
Dalfampridine—KCNH2—cardiac atrium—muscle cancer	0.0028	0.00295	CbGeAlD
Dalfampridine—CYP2E1—renal system—muscle cancer	0.00241	0.00254	CbGeAlD
Dalfampridine—KCNH2—bone marrow—muscle cancer	0.00237	0.00249	CbGeAlD
Dalfampridine—KCNH2—vagina—muscle cancer	0.00227	0.00239	CbGeAlD
Dalfampridine—KCNH2—head—muscle cancer	0.00209	0.0022	CbGeAlD
Dalfampridine—KCNH2—testis—muscle cancer	0.00202	0.00213	CbGeAlD
Dalfampridine—CYP2E1—tendon—muscle cancer	0.00188	0.00198	CbGeAlD
Dalfampridine—CYP2E1—head—muscle cancer	0.00161	0.0017	CbGeAlD
Dalfampridine—Chest discomfort—Etoposide—muscle cancer	0.00159	0.0323	CcSEcCtD
Dalfampridine—CYP2E1—testis—muscle cancer	0.00156	0.00164	CbGeAlD
Dalfampridine—Connective tissue disorder—Vincristine—muscle cancer	0.000856	0.0174	CcSEcCtD
Dalfampridine—Angiopathy—Vincristine—muscle cancer	0.000791	0.0161	CcSEcCtD
Dalfampridine—Infestation NOS—Etoposide—muscle cancer	0.000786	0.016	CcSEcCtD
Dalfampridine—Infestation—Etoposide—muscle cancer	0.000786	0.016	CcSEcCtD
Dalfampridine—Mediastinal disorder—Vincristine—muscle cancer	0.000785	0.0159	CcSEcCtD
Dalfampridine—Mental disorder—Vincristine—muscle cancer	0.000764	0.0155	CcSEcCtD
Dalfampridine—Back pain—Vincristine—muscle cancer	0.000734	0.0149	CcSEcCtD
Dalfampridine—Infection—Dactinomycin—muscle cancer	0.000688	0.014	CcSEcCtD
Dalfampridine—Convulsion—Vincristine—muscle cancer	0.000657	0.0133	CcSEcCtD
Dalfampridine—Angiopathy—Etoposide—muscle cancer	0.000641	0.013	CcSEcCtD
Dalfampridine—Immune system disorder—Etoposide—muscle cancer	0.000638	0.0129	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—muscle cancer	0.000636	0.0129	CcSEcCtD
Dalfampridine—Anaphylactic shock—Vincristine—muscle cancer	0.000619	0.0126	CcSEcCtD
Dalfampridine—Infection—Vincristine—muscle cancer	0.000615	0.0125	CcSEcCtD
Dalfampridine—Nervous system disorder—Vincristine—muscle cancer	0.000607	0.0123	CcSEcCtD
Dalfampridine—Back pain—Etoposide—muscle cancer	0.000594	0.0121	CcSEcCtD
Dalfampridine—Hypotension—Vincristine—muscle cancer	0.000579	0.0117	CcSEcCtD
Dalfampridine—Feeling abnormal—Dactinomycin—muscle cancer	0.000571	0.0116	CcSEcCtD
Dalfampridine—Insomnia—Vincristine—muscle cancer	0.00056	0.0114	CcSEcCtD
Dalfampridine—Paraesthesia—Vincristine—muscle cancer	0.000556	0.0113	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000535	0.0109	CcSEcCtD
Dalfampridine—Convulsion—Etoposide—muscle cancer	0.000532	0.0108	CcSEcCtD
Dalfampridine—Constipation—Vincristine—muscle cancer	0.000529	0.0108	CcSEcCtD
Dalfampridine—Chest pain—Etoposide—muscle cancer	0.000523	0.0106	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00052	0.0105	CcSEcCtD
Dalfampridine—Hypersensitivity—Dactinomycin—muscle cancer	0.000511	0.0104	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—muscle cancer	0.000506	0.0103	CcSEcCtD
Dalfampridine—Anaphylactic shock—Etoposide—muscle cancer	0.000502	0.0102	CcSEcCtD
Dalfampridine—Infection—Etoposide—muscle cancer	0.000498	0.0101	CcSEcCtD
Dalfampridine—Asthenia—Dactinomycin—muscle cancer	0.000497	0.0101	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—muscle cancer	0.000487	0.00989	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000473	0.00961	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—muscle cancer	0.000471	0.00956	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—muscle cancer	0.000471	0.00956	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—muscle cancer	0.000469	0.00952	CcSEcCtD
Dalfampridine—Hypersensitivity—Vincristine—muscle cancer	0.000456	0.00926	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—muscle cancer	0.00045	0.00914	CcSEcCtD
Dalfampridine—Dyspnoea—Etoposide—muscle cancer	0.000447	0.00908	CcSEcCtD
Dalfampridine—Asthenia—Vincristine—muscle cancer	0.000444	0.00902	CcSEcCtD
Dalfampridine—Vomiting—Dactinomycin—muscle cancer	0.000441	0.00895	CcSEcCtD
Dalfampridine—Rash—Dactinomycin—muscle cancer	0.000437	0.00887	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000433	0.00879	CcSEcCtD
Dalfampridine—Constipation—Etoposide—muscle cancer	0.000429	0.00871	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—muscle cancer	0.000413	0.00839	CcSEcCtD
Dalfampridine—Nausea—Dactinomycin—muscle cancer	0.000412	0.00836	CcSEcCtD
Dalfampridine—Dizziness—Vincristine—muscle cancer	0.000409	0.00831	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—muscle cancer	0.000408	0.00828	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—muscle cancer	0.000408	0.00828	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—muscle cancer	0.000398	0.00809	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—muscle cancer	0.000396	0.00805	CcSEcCtD
Dalfampridine—Vomiting—Vincristine—muscle cancer	0.000394	0.00799	CcSEcCtD
Dalfampridine—Rash—Vincristine—muscle cancer	0.00039	0.00793	CcSEcCtD
Dalfampridine—Dermatitis—Vincristine—muscle cancer	0.00039	0.00792	CcSEcCtD
Dalfampridine—Headache—Vincristine—muscle cancer	0.000388	0.00788	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—muscle cancer	0.000384	0.00779	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—muscle cancer	0.000382	0.00775	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—muscle cancer	0.000381	0.00774	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—muscle cancer	0.00037	0.00752	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—muscle cancer	0.00037	0.0075	CcSEcCtD
Dalfampridine—Nausea—Vincristine—muscle cancer	0.000368	0.00747	CcSEcCtD
Dalfampridine—Asthenia—Etoposide—muscle cancer	0.00036	0.00731	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—muscle cancer	0.00036	0.00731	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—muscle cancer	0.000356	0.00723	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—muscle cancer	0.000332	0.00675	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—muscle cancer	0.000332	0.00673	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—muscle cancer	0.000331	0.00672	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00033	0.0067	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—muscle cancer	0.000321	0.00651	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—muscle cancer	0.000319	0.00648	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—muscle cancer	0.000319	0.00647	CcSEcCtD
Dalfampridine—Rash—Etoposide—muscle cancer	0.000316	0.00642	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—muscle cancer	0.000316	0.00641	CcSEcCtD
Dalfampridine—Headache—Etoposide—muscle cancer	0.000314	0.00638	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—muscle cancer	0.000313	0.00636	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000311	0.00632	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—muscle cancer	0.000308	0.00626	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—muscle cancer	0.000303	0.00615	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—muscle cancer	0.0003	0.0061	CcSEcCtD
Dalfampridine—Infection—Methotrexate—muscle cancer	0.000298	0.00606	CcSEcCtD
Dalfampridine—Nausea—Etoposide—muscle cancer	0.000298	0.00605	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—muscle cancer	0.000295	0.00598	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—muscle cancer	0.000292	0.00592	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—muscle cancer	0.000281	0.0057	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—muscle cancer	0.000276	0.00561	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—muscle cancer	0.000272	0.00552	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—muscle cancer	0.000271	0.00551	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—muscle cancer	0.00027	0.00549	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—muscle cancer	0.00027	0.00548	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00027	0.00547	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—muscle cancer	0.000268	0.00544	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—muscle cancer	0.000264	0.00537	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—muscle cancer	0.000262	0.00533	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00026	0.00528	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000259	0.00527	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—muscle cancer	0.000258	0.00525	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—muscle cancer	0.000255	0.00518	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—muscle cancer	0.000253	0.00513	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—muscle cancer	0.000248	0.00503	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—muscle cancer	0.000243	0.00494	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—muscle cancer	0.000239	0.00485	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—muscle cancer	0.000235	0.00478	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—muscle cancer	0.000234	0.00474	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—muscle cancer	0.000232	0.00471	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—muscle cancer	0.000229	0.00465	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000225	0.00456	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—muscle cancer	0.000222	0.00452	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—muscle cancer	0.000221	0.00449	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—muscle cancer	0.000216	0.00438	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—muscle cancer	0.000214	0.00435	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—muscle cancer	0.000207	0.0042	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—muscle cancer	0.000199	0.00403	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—muscle cancer	0.000192	0.00389	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—muscle cancer	0.000191	0.00388	CcSEcCtD
Dalfampridine—Rash—Methotrexate—muscle cancer	0.000189	0.00385	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—muscle cancer	0.000189	0.00384	CcSEcCtD
Dalfampridine—Headache—Methotrexate—muscle cancer	0.000188	0.00382	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—muscle cancer	0.000187	0.00379	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—muscle cancer	0.000178	0.00362	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—muscle cancer	0.000172	0.00349	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—muscle cancer	0.000165	0.00336	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—muscle cancer	0.000164	0.00333	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—muscle cancer	0.000164	0.00333	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—muscle cancer	0.000163	0.00331	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—muscle cancer	0.000155	0.00314	CcSEcCtD
